Jay Allan Barth - Net Worth and Insider Trading

Jay Allan Barth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jay Allan Barth owns 1 companies in total, including PTC Therapeutics Inc (PTCT) .

Click here to see the complete history of Jay Allan Barth’s form 4 insider trades.

Insider Ownership Summary of Jay Allan Barth

Ticker	Comapny	Transaction Date	Type of Owner
PTCT	PTC Therapeutics Inc	2013-06-19	VP & Clinical Development

Jay Allan Barth Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jay Allan Barth Ownership Network

Ownership Network List of Jay Allan Barth

No Data

Ownership Network Relation of Jay Allan Barth

Jay Allan Barth Owned Company Details

What does PTC Therapeutics Inc do?

Who are the key executives at PTC Therapeutics Inc?

Jay Allan Barth is the VP & Clinical Development of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .

PTC Therapeutics Inc (PTCT) Insider Trades Summary

Over the past 18 months, Jay Allan Barth made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,039 shares made by Eric Pauwels , a net sale of 22,455 shares made by Matthew B. Klein , and a net sale of 2,701 shares made by Lee Scott Golden .

In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,302 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 106,602 shares.

PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

PTC Therapeutics Inc Insider Transactions

No Available Data

Jay Allan Barth Mailing Address

Above is the net worth, insider trading, and ownership report for Jay Allan Barth. You might contact Jay Allan Barth via mailing address: Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.